According to Glaukos's latest financial reports the company's current revenue (TTM) is $0.31 B. In 2022 the company made a revenue of $0.28 B a decrease over the years 2021 revenue that were of $0.29 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.31 B | 11.26% |
2022 | $0.28 B | -3.79% |
2021 | $0.29 B | 30.7% |
2020 | $0.22 B | -5.07% |
2019 | $0.23 B | 30.73% |
2018 | $0.18 B | 13.83% |
2017 | $0.15 B | 39.21% |
2016 | $0.11 B | 59.55% |
2015 | $71.7 M | 57.28% |
2014 | $45.58 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ICU Medical
ICUI | $2.25 B | 617.84% | ๐บ๐ธ USA |
AtriCure ATRC | $0.39 B | 26.86% | ๐บ๐ธ USA |
Integra LifeSciences IART | $1.54 B | 389.84% | ๐บ๐ธ USA |
Hill-Rom HRC | $3.01 B | 859.20% | ๐บ๐ธ USA |